Company:  BIOMX INC. (PHGE)
Form Type:  SC 13G
Filing Date:  11/6/2019 
CIK:  0001739174 
Address:  17 STATE STREET, 16TH FLOOR 
City, State, Zip:  NEW YORK, New York 10004 
Telephone:  646-465-9000 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$7.12  
Change: 
-0.86 (-10.78%)  
Trade Time: 
10:57 AM EST  
Market Cap: 
$163.23M
Trade PHGE now with 

© 2020  
Description of Business
BiomX is an Israeli company formed on March 3, 2015. It is a clinical stage microbiome product discovery company developing products using both natural and engineered phage technologies designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease ("IBD"), liver disease and cancer. Bacteriophage or phage are viruses that target bacteria and are considered inert to mammalian cells. By utilizing proprietary combinations of naturally occurring phage and by creating novel phage using synthetic biology, BiomX develops phage-based therapies intended to address large-market and orphan diseases.
Register and access this filing in:     
  FORM SC 13G
  EXHIBIT 99.1
  EXHIBIT 99.2